Detalhe da pesquisa
1.
The Antimalarial Mefloquine Shows Activity against Mycobacterium abscessus, Inhibiting Mycolic Acid Metabolism.
Int J Mol Sci
; 22(16)2021 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34445239
2.
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
Antimicrob Agents Chemother
; 63(7)2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31010861
3.
Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH.
Antimicrob Agents Chemother
; 61(3)2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27993848
4.
Pseudo-outbreak of Mycobacterium gordonae in a teaching hospital: importance of strictly following decontamination procedures and emerging issues concerning sterilization.
New Microbiol
; 39(1): 25-34, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26922983
5.
Towards tuberculosis elimination: an action framework for low-incidence countries.
Eur Respir J
; 45(4): 928-52, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25792630
6.
Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 58(12): 7527-33, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25288092
7.
Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions.
Antimicrob Agents Chemother
; 57(3): 1428-33, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23295931
8.
Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009-2016.
Eur Respir J
; 52(1)2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29724919
9.
Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculum.
J Clin Microbiol
; 51(1): 291-4, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23100351
10.
Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020.
Ann Ist Super Sanita
; 59(2): 132-138, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37337988
11.
Eradication of Drug-Tolerant Mycobacterium tuberculosis 2022: Where We Stand.
Microorganisms
; 11(6)2023 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37375013
12.
Moving towards tuberculosis elimination: a call for action from Italy and a possible model for other low tuberculosis incidence countries.
Eur Respir J
; 49(2)2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28153873
13.
GenoType MTBDRsl performance on clinical samples with diverse genetic background.
Eur Respir J
; 40(3): 690-8, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22267773
14.
Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide Resistance.
J Clin Microbiol
; 55(12): 3552-3553, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28904184
15.
Activity of Drug Combinations against Mycobacterium abscessus Grown in Aerobic and Hypoxic Conditions.
Microorganisms
; 10(7)2022 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35889140
16.
Tuberculosis in migrants from 106 countries to Italy, 2008-2014.
Eur Respir J
; 47(4): 1273-6, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26846829
17.
Expression of proinflammatory and regulatory cytokines via NF-κB and MAPK-dependent and IFN regulatory factor-3-independent mechanisms in human primary monocytes infected by Mycobacterium tuberculosis.
Clin Dev Immunol
; 2011: 841346, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21197399
18.
Moxifloxacin Activates the SOS Response in Mycobacterium tuberculosis in a Dose- and Time-Dependent Manner.
Microorganisms
; 9(2)2021 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33513836
19.
Mycobacterium tuberculosis and SARS-CoV-2 Coinfections: A Review.
Front Microbiol
; 12: 747827, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35185809
20.
Activity of drug combinations against dormant Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 54(6): 2712-5, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20350948